Clinical Trial Update: Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA [Phase 3]

View source ↗

Summary

Phase 3 trial comparing six months versus twelve months of oral itraconazole for treatment-naïve chronic pulmonary aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Aspergillosis

Drugs mentioned

• Itraconazole (Itraconazole)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Chronic Pulmonary Aspergillosis | Phase 3 | Status: COMPLETED